Assembly Biosciences (ASMB) Other Working Capital Changes (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Other Working Capital Changes of -$7.8 million for Q1 2026, up 16.89% year-over-year from -$6.7 million in Q1 2025, and down 9.12% quarter-over-quarter from -$7.2 million in Q4 2025.
Assembly Biosciences (ASMB) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Assembly Biosciences' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$7.8 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 16.89% year-over-year to -$7.8 million; the TTM figure through Mar 2026 stood at -$34.5 million (down 103.83% YoY), while the FY2025 annual figure was -$36.1 million, down 171.52% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$7.8 million, down from -$7.2 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $1.1 million in Q1 2025, with the low at -$2.6 million in Q3 2022.
- The 5-year median for Other Working Capital Changes is -$195000.0 (2025), against an average of -$312823.5.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes tumbled 191.17% in 2025, then climbed 16.89% in 2026.
- Assembly Biosciences' Other Working Capital Changes stood at $83.6 million in 2023, then tumbled by 90.58% to $7.9 million in 2024, then slumped by 191.17% to -$7.2 million in 2025, then fell by 9.12% to -$7.8 million in 2026.
- Business Quant data shows ASMB's Other Working Capital Changes at -$7.8 million in Q1 2026, -$7.2 million in Q4 2025, and -$9.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Mn |
| Jun 30, 2026 | 1.53 Mn |
| Jun 30, 2026 | 1.53 Mn |
| Mar 31, 2026 | 92,000.00 |
| Mar 31, 2026 | 92,000.00 |
| Mar 31, 2026 | 92,000.00 |
| Dec 31, 2025 | -195,000.00 |
| Dec 31, 2025 | -195,000.00 |
| Dec 31, 2025 | -195,000.00 |
| Sep 30, 2025 | 381,000.00 |
| Sep 30, 2025 | 381,000.00 |
| Sep 30, 2025 | 381,000.00 |
| Jun 30, 2025 | -2.01 Mn |
| Jun 30, 2025 | -2.01 Mn |
| Jun 30, 2025 | -2.01 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 165,000.00 |
| Dec 31, 2024 | 165,000.00 |